Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.

Market Cap 809M 160M 138M 127M 119M 223M 15.17B 226M 1.5B 585M 7.38B 599M 586M 25.56B P/E Ratio 2024
6.95x
P/E Ratio 2025 9.42x
Enterprise Value 1.98B 390M 336M 310M 290M 544M 37.03B 552M 3.66B 1.43B 18.02B 1.46B 1.43B 62.41B EV / Sales 2024
0.18x
EV / Sales 2025 0.2x
Free-Float
32.86%
Yield 2024
8.86%
Yield 2025 -
05-06 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-15 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 CI
03-03 Brazil's Profarma to buy 4Bio from Raia Drogasil in 600 mln reais deal RE
11-05 Bmk, Bpl negotiate potential acquisition of Bpl shares in Brazil's Profarma RE
25-10-30 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-07-31 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-04 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-18 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 CI
25-03-18 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
24-10-30 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-06 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-07 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-06 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
1 day+4.10%
1 week-1.20%
Current month-6.38%
1 month-6.52%
3 months-19.32%
6 months-23.96%
Current year-27.71%
1 week 6.2
Extreme 6.2
6.69
1 month 6.2
Extreme 6.2
7.11
Current year 6.2
Extreme 6.2
9.7
1 year 6.2
Extreme 6.2
9.7
3 years 3.4
Extreme 3.4
9.7
5 years 2.92
Extreme 2.92
9.7
10 years 2.87
Extreme 2.87
11.79
Manager TitleAgeSince
Chief Executive Officer 57 2010-04-20
Director of Finance/CFO 68 1992-12-31
Director TitleAgeSince
Chairman 57 2008-04-02
Director/Board Member 91 2010-04-20
Director/Board Member - 2020-06-09
Date Insider Type Main position Quantity % Market Cap.
25-08-07Others 1 0.0000%
24-12-08Sell 20,000 0.0162%
24-12-08Sell 7,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+4.10%-1.20%-24.49%+61.76% 156M
-0.40%+1.08%+7.29%+98.36% 94.62B
+1.22%+8.82%+39.45%+156.77% 51.8B
-1.86%-9.59%-18.01%+230.00% 21.64B
+0.62%+0.49%-11.87%-26.06% 8.05B
-0.07%+2.43%-35.41%-27.86% 7.54B
+1.19%-1.22%-11.27%-36.33% 6.69B
-2.80%-2.46%+9.63%+20.45% 6.63B
+0.30%+1.01%-1.34%+17.66% 5.28B
+1.27%-3.62%-12.11%-15.86% 3.48B
Average +0.36%+0.69%-5.81%+47.89% 20.59B
Weighted average by Cap. -0.07%+3.73%+9.31%+106.49%

Financials

2024 2025
Net sales 10.15B 2B 1.73B 1.59B 1.49B 2.8B 190B 2.84B 18.81B 7.34B 92.62B 7.51B 7.35B 321B 11.45B 2.26B 1.95B 1.8B 1.68B 3.15B 215B 3.2B 21.22B 8.27B 104B 8.47B 8.29B 362B
Net income 115M 22.59M 19.51M 17.98M 16.83M 31.54M 2.15B 32.03M 212M 82.77M 1.05B 84.78M 82.98M 3.62B 119M 23.44M 20.25M 18.66M 17.46M 32.73M 2.23B 33.24M 220M 85.89M 1.08B 87.98M 86.1M 3.76B
Net Debt 1.02B 201M 173M 160M 149M 280M 19.06B 284M 1.88B 735M 9.28B 753M 737M 32.13B 1.17B 230M 199M 183M 171M 321M 21.86B 326M 2.16B 843M 10.64B 863M 845M 36.85B
Logo Profarma Distribuidora de Produtos Farmacêuticos S.A.
Profarma Distribuidora de Produtos Farmaceuticos SA is a Brazil-based company primarily engaged in the wholesale trading of drugs. The Company's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The Company's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Employees
7,077
Date Price Change Volume
26-06-12 6.600 R$ +0.92% 159,300
26-06-11 6.540 R$ +4.14% 110,200
26-06-10 6.280 R$ -0.95% 92,600
26-06-09 6.340 R$ -2.46% 186,400
26-06-08 6.500 R$ -2.69% 155,900
  1. Stock Market
  2. Stocks
  3. PFRM3 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!